852 related articles for article (PubMed ID: 25469007)
1. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.
Bezzio C; Festa S; Saibeni S; Papi C
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825
[TBL] [Abstract][Full Text] [Related]
5. [Colorectal cancer in ulcerative colitis].
Laugesen KB; Tøttrup A
Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colorectal cancer in ulcerative colitis.
Croog VJ; Ullman TA; Itzkowitz SH
Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
[TBL] [Abstract][Full Text] [Related]
7. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
8. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
9. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U
Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease cancer risk, detection and surveillance.
Rogler G
Dig Dis; 2012; 30 Suppl 2():48-54. PubMed ID: 23207932
[TBL] [Abstract][Full Text] [Related]
12. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
13. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
14. Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
Hata K; Anzai H; Ikeuchi H; Futami K; Fukushima K; Sugita A; Uchino M; Higashi D; Itabashi M; Watanabe K; Koganei K; Araki T; Kimura H; Mizushima T; Ueda T; Ishihara S; Suzuki Y;
Am J Gastroenterol; 2019 Mar; 114(3):483-489. PubMed ID: 30747769
[TBL] [Abstract][Full Text] [Related]
15. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
[TBL] [Abstract][Full Text] [Related]
17. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
